Applied DNA Sciences Inc. received notification on May 30, 2025, from Nasdaq that it failed to meet the minimum $1.00 bid price for continued listing, triggered by a closing bid price below this threshold for 32 consecutive business days. To regain compliance, the company executed a 1-for-15 reverse stock split effective June 2, 2025, and has requested a hearing to avoid delisting.